Related references
Note: Only part of the references are listed.Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4)
Taj Mohammad et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2019)
Design and development of Isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis
Babita Aneja et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of a Prenylated Flavonol Derivative as a Pin1 Inhibitor to Suppress Hepatocellular Carcinoma by Modulating MicroRNA Biogenesis
Yuanyuan Zheng et al.
CHEMISTRY-AN ASIAN JOURNAL (2019)
Pin1 impairs microRNA biogenesis by mediating conformation change of XPO5 in hepatocellular carcinoma
Jiao Li et al.
CELL DEATH AND DIFFERENTIATION (2018)
SKLB060 Reversibly Binds to Colchicine Site of Tubulin and Possesses Efficacy in Multidrug-Resistant Cell Lines
Wei Yan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Coumarin Compounds in Medicinal Chemistry: Some Important Examples from the Last Years
Thiago Moreira Pereira et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)
Targeting Pin1 by inhibitor API-1 regulates microRNA biogenesis and suppresses hepatocellular carcinoma development
Wenchen Pu et al.
HEPATOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Synthesis, molecular docking and inhibition studies of novel 3-N-aryl substituted-2-heteroarylchromones targeting microtubule affinity regulating kinase 4 inhibitors
Iram Parveen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-B Pathways
Dionisio A. Olmedo et al.
MOLECULES (2017)
Elucidation of Dietary Polyphenolics as Potential Inhibitor of Microtubule Affinity Regulating Kinase 4: In silico and In vitro Studies
Parvez Khan et al.
SCIENTIFIC REPORTS (2017)
N-Heterocyclic-Carbene-Catalyzed Redox Lactonization of o-Hydroxycinnamaldehydes and o-Hydroxycinnamyl Alcohols to Coumarins
Jingjing Meng et al.
ASIAN JOURNAL OF ORGANIC CHEMISTRY (2017)
Structure guided design of a series of selective pyrrolopyrimidinone MARK inhibitors
Jason D. Katz et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
MARK4 inhibits Hippo signaling to promote proliferation and migration of breast cancer cells
Emad Heidary Arash et al.
EMBO REPORTS (2017)
ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5
Hui-Lung Sun et al.
CANCER CELL (2016)
A Review on Chemical Profile of Coumarins and their Therapeutic Role in the Treatment of Cancer
K. Venkata Sairam et al.
CURRENT DRUG DELIVERY (2016)
Crystal structure of microtubule affinity-regulating kinase 4 catalytic domain in complex with a pyrazolopyrimidine inhibitor
John S. Sack et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2016)
Current developments of coumarin-based anti-cancer agents in medicinal chemistry
Saeed Emami et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
miR-122-A key factor and therapeutic target in liver disease
Simonetta Bandiera et al.
JOURNAL OF HEPATOLOGY (2015)
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial
Sandro Pignata et al.
LANCET ONCOLOGY (2015)
Designing New Kinase Inhibitor Derivatives as Therapeutics Against Common Complex Diseases: Structural Basis of Microtubule Affinity-Regulating Kinase 4 (MARK4) Inhibition
Farha Naz et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2015)
3-Arylcoumarins: Synthesis and potent anti-inflammatory activity
Wenchen Pu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Microtubule-associated protein/microtubule affinity-regulating kinase 4 (MARK4) plays a role in cell cycle progression and cytoskeletal dynamics
Davide Rovina et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2014)
The structural analysis of MARK4 and the exploration of specific inhibitors for the MARK family: a computational approach to obstruct the role of MARK4 in prostate cancer progression
Pranitha Jenardhanan et al.
MOLECULAR BIOSYSTEMS (2014)
An AMPK-Independent Signaling Pathway Downstream of the LKB1 Tumor Suppressor Controls Snail1 and Metastatic Potential
Jonathan M. Goodwin et al.
MOLECULAR CELL (2014)
Copper-catalyzed decarboxylative intramolecular C-O coupling: synthesis of 2-arylbenzofuran from 3-arylcoumarin
Wen-Chen Pu et al.
RSC ADVANCES (2014)
Amine-Catalyzed Cascade Synthesis of 3,4-Diunsubstituted Coumarins
Jia Wei et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2013)
Gemcitabine-Coumarin-Biotin Conjugates: A Target Specific Theranostic Anticancer Prodrug
Sukhendu Maiti et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Synthesis and cytotoxic activity of non-naturally substituted 4-oxycoumarin derivatives
Silvia Serra et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Synthesis and antioxidant activities of novel 4-Schiff base-7-benzyloxy-coumarin derivatives
Ye Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Natural Taxanes: Developments Since 1828
Yu-Fang Wang et al.
CHEMICAL REVIEWS (2011)
Efficient synthesis and biological evaluation of 4-arylcoumarin derivatives
Jie Sun et al.
CHINESE CHEMICAL LETTERS (2011)
Microtubules and resistance to tubulin-binding agents
Maria Kavallaris
NATURE REVIEWS CANCER (2010)
Synthesis and antioxidant activity of selected 4-methylcoumarins
Sanja Cavar et al.
FOOD CHEMISTRY (2009)
The tau of MARK: a polarized view of the cytoskeleton
Dorthe Matenia et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
Synthesis and biological evaluation of alkoxycoumarins as novel nematicidal constituents
Kazuto Takaishi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Microtubules do not promote mitotic slippage when the spindle assembly checkpoint cannot be satisfied
Daniela A. Brito et al.
JOURNAL OF CELL BIOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma – We have won a battle not the war
Peter R. Galle
JOURNAL OF HEPATOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
L-proline catalyzed solvent-free Knoevenagel condensation for the synthesis of 3-substituted coumarins
Nandkishor N. Karade et al.
CHINESE JOURNAL OF CHEMISTRY (2007)
Condensation of α-aroylketene dithioacetals and 2-hydroxyarylaldehydes results in facile synthesis of a combinatorial library of 3-aroylcoumarins
H. Surya Prakash Rao et al.
JOURNAL OF ORGANIC CHEMISTRY (2006)
Novel small molecule inhibitors of 3-phosphoinositide-dependent kinase-1
RI Feldman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Microtubules as a target for anticancer drugs
MA Jordan et al.
NATURE REVIEWS CANCER (2004)
The spindle checkpoint, aneuploidy, and cancer
R Bharadwaj et al.
ONCOGENE (2004)
MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes
B Trinczek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The neural progenitor-restricted isoform of the MARK4 gene in 19q13.2 is upregulated in human gliomas and overexpressed in a subset of glioblastoma cell lines
A Beghini et al.
ONCOGENE (2003)
Solvent-free coumarin synthesis
T Sugino et al.
CHEMISTRY LETTERS (2001)
Share Paper
